FDA Drug Application (090602) for NIFEDIPINE by MATRIX LABS LTD

Back to FDA Applications sponsored by MATRIX LABS LTD

Application Number090602
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNIFEDIPINE
Active IngredientNIFEDIPINE

Active IngredientCount
List of drugs with Active Ingredient NIFEDIPINE6


Back to FDA Applications sponsored by MATRIX LABS LTD